Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32-1 - AIM ImmunoTech Inc. | s102655_ex32-1.htm |
| EX-31.2 - EXHIBIT 31-2 - AIM ImmunoTech Inc. | s102655_ex31-2.htm |
| EX-32.2 - EXHIBIT 32-2 - AIM ImmunoTech Inc. | s102655_ex32-2.htm |
| EX-31.1 - EXHIBIT 31-1 - AIM ImmunoTech Inc. | s102655_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - AIM ImmunoTech Inc. | s102655_ex21-1.htm |
| 10-K - FORM 10-K - AIM ImmunoTech Inc. | s102655_10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Hemispherx Biopharma, Inc.
Philadelphia, Pennsylvania
We consent to the incorporation by reference in Registration Statements (No. 333-160499, 333-57134, 118903, 333-155528 and 333-209060) on Form S-8 and Registration Statements (No. 333-182216, 333-152727, 333-126804, 333-130008, 333-159856, 333-151696 and 333-205228) on Form S-3 of Hemispherx Biopharma, Inc. and Subsidiaries of our report dated March 29, 2016 relating to our audit of the consolidated financial statements which appears in this Annual Report on Form 10-K of Hemispherx Biopharma, Inc. for the year ended December 31, 2015.
| /s/ RSM US LLP |
| RSM US LLP |
Blue Bell, Pennsylvania
March 29, 2016